Further, several equine PRP studies have validated these ELISA kits [ 6, 14- 16].
Several studies have validated Danish databases.
Since the PORPUS-P has a 0 to 100 point scale, we assume a difference of 5 points is clinically relevant (but further studies have to validate this assumption).
Further studies have to be performed which validate our simulation results in a clinical setup and which address the clinical consequences of this vignetting effect more in detail.
Further studies have to be performed to validate our findings in the human system and to identify the serum factor(s) causative for the observed cellular and molecular alterations.
However, further studies have to be conducted to fully validate this approach.
However, further studies have to be done in order to validate this approach and to confirm that the accuracy is sufficient for diagnostic purposes [ 15].
In particular, we have validated and further studied: HMGCR (encoding HMG-CoA reductase), farnesyl pyrophosphate synthase (FPPS) (also known as FDPS, Supplementary Table 2), Sterol Element Binding Protein (SREBP -1 and SREBP -1 low-density lipoprotein receptor (LDL-R), cyclins B1 and D1, aurora kinases A and B, survivin, p21 and p27 (Supplementary Table 3).
Other studies have further validated this requirement (Turner et al. 2009), suggesting that the endogenous mechanism in human cells whereby ncRNAs regulate gene transcription may involve forms of RNA beyond double-stranded RNAs.
Further studies will have to validate the need for personalized treatments – mostly psychotherapies - [ 16, 181] and for interventions tailored to personality dimensions to attenuate resistance and prevent dropouts.
Another recent study has further validated the notion that EndMT can occur postnatally in the context of disease.
